ArticleFrontiers in oncology2020

MEK Inhibitor Augments Antitumor Activity of B7-H3-Redirected Bispecific Antibody.

Hongjian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.